Antenatal corticosteroid timing is one of the most vital clinical decisions in managing anticipated preterm birth. Achieving the optimal window is critical for maximising benefit and reducing potential harm. A recent retrospective cohort study sought to provide real-world data on factors influencing optimal timing for women delivering between 24 0/7 and 33 6/7 weeks of gestation.
The study defined optimal timing as delivery occurring between 6 hours and 7 days after the first corticosteroid dose. Conversely, delivery less than 6 hours or more than 7 days later was considered suboptimal. Furthermore, the researchers also examined patients who received steroids before 34 weeks but subsequently delivered at term, an indicator of potential overuse.
Challenges in Antenatal Corticosteroid Timing
This study analyzed 1,694 pregnant patients who delivered preterm. The results clearly highlight the challenge in predicting delivery accurately. Only 961 patients (56.7%) received optimally timed antenatal corticosteroid administration. Meanwhile, 162 patients (9.6%) delivered too quickly, less than six hours after the first dose. Also, 320 patients (18.9%) delivered more than seven days later, indicating a transient drug effect. Significantly, 251 patients (14.8%) did not receive any antenatal corticosteroids at all before delivery.
The issue of overuse also appears substantial. Of all women who received antenatal steroids before 34 weeks, 25.9% (747 of 2,879) went on to deliver at term (after 37 weeks). Therefore, clinicians must improve the prediction of imminent preterm delivery. Indian guidelines, for example, recommend against administration beyond 34 weeks, underscoring the importance of this cut-off.
Clinical Factors Associated with Optimal Timing
Investigators used multivariable logistic regression modeling to identify factors associated with achieving optimal timing versus delivering more than seven days later. Importantly, several clinical factors showed a positive correlation with timely administration. For instance, pregnancy-related hypertensive disorders demonstrated a significantly higher likelihood of optimal timing (aOR 1.88). Preterm labor also showed a strong positive association (aOR 2.78). Premature rupture of membranes (PROM) was likewise correlated with timely administration (1.37).
Conversely, certain patient factors and diagnoses were associated with suboptimal timing (delivery >7 days after administration). These included anxiety disorder (aOR 0.79), multiparity with no history of preterm birth (aOR 0.81), placenta previa (aOR 0.76), and placenta accreta (aOR 0.83). Consequently, care providers must exercise caution when administering steroids to women with these specific conditions, given the lower likelihood of a timely delivery within the optimal window. The optimal window, generally 2 to 7 days, ensures maximum fetal lung maturity benefit.
Maximizing Benefit and Minimizing Exposure
The primary finding underscores the ongoing difficulty in accurately predicting preterm birth. Doctors must therefore adopt an individualized patient assessment approach. Improving prediction models ensures women at true risk receive timely access to the intervention. Furthermore, limiting unnecessary exposure is equally crucial. Studies have shown that administration more than seven days before delivery increases the risk of both severe neonatal and childhood morbidities. Consequently, senior obstetric input and stringent assessment are advisable before administering these steroids, especially in a system where delivery timing is often unpredictable.
Frequently Asked Questions
Q1: What is the optimal Antenatal corticosteroid timing window for preterm delivery?
The optimal timing is generally considered to be when delivery occurs between 6 hours and 7 days after the first dose of antenatal corticosteroids. This window maximizes the drug’s effect on fetal lung maturation.
Q2: What percentage of patients in the study received suboptimally timed antenatal corticosteroids?
In the study, 9.6% of patients delivered less than 6 hours after the first dose (too early for full effect), and 18.9% delivered more than 7 days after administration (outside the maximum efficacy window).
Q3: Which clinical conditions were associated with achieving optimal timing?
Clinical factors strongly associated with optimally timed administration included pregnancy-related hypertensive disorders, preterm labor, and premature rupture of membranes.
References
- Clapp MA et al. Maximizing Benefit From Antenatal Steroid Use While Avoiding Overuse. Obstet Gynecol. 2026 Feb 05. doi: 10.1097/AOG.0000000000006178. PMID: 41643200.
- Antenatal Corticosteroid Therapy for Preterm Birth. WHO and Government of India guidelines.
- Administration of Antenatal Corticosteroids: Optimal Timing. Dtsch Arztebl Int. 2024 Jan 03. doi: 10.3238/arztebl.m2023.0305.